Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
Clinical trial NCT06496789 · UNKNOWN
Trial details
- NCT number
- NCT06496789
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-27
- Primary completion
- 2024-12-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.